Enhanced Hematoma Membrane on DynaCT Images During Middle Meningeal Artery Embolization for Persistently Recurrent Chronic Subdural Hematoma
- PMID: 30825631
- DOI: 10.1016/j.wneu.2019.02.074
Enhanced Hematoma Membrane on DynaCT Images During Middle Meningeal Artery Embolization for Persistently Recurrent Chronic Subdural Hematoma
Abstract
Objective: Chronic subdural hematoma (CSDH) is generally treated by burr-hole irrigation, but it can recur despite repeating these procedures. Embolization of the middle meningeal artery (MMA) has recently been proposed as a curative treatment for CSDH, but evidence for the indication and timing of MMA embolization is not definitive. The present study retrospectively analyzed the effects and safety of MMA embolization among patients with persistent CSDH recurrence.
Methods: We retrospectively assessed data from 381 consecutive patients who underwent burr-hole irrigation for CSDH between 2009 and 2017. Recurrent symptomatic ipsilateral CSDH in 71 (18%) patients was treated by a second burr-hole irrigation, and 20 of them had a further symptomatic CSDH recurrence thereafter. Those with persistent ipsilateral CSDH recurrence were treated by MMA embolization. Before the MMA embolization procedures, the amount of hematoma membrane enhancement determined using superselective MMA angiography-DynaCT imaging was classified into 3 stages.
Results: Embolization of the MMA proceeded without perioperative complications or further CSDH recurrence. The interval between recurrence and the amount of hematoma membrane enhancement significantly correlated (first to second and second to third treatments: P = 0.012 and P = 0.017, respectively). The frequency of bilateral CSDH was significantly higher and the recurrence interval between the first and second treatments was significantly shorter in the repeated recurrences group compared with the recurrence group (P = 0.023 and P = 0.006, respectively).
Conclusions: Repeatedly recurrent CSDH can be safely treated and cured by MMA embolization. Hematoma membrane enhancement pattern using DynaCT images can predict repeated recurrences CSDH.
Keywords: Chronic subdural hematoma; Cone-beam computed tomography; Embolization; Hematoma membrane; Middle meningeal artery.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
Midterm Follow-Up of Patients with Middle Meningeal Artery Embolization in Intractable Chronic Subdural Hematoma.World Neurosurg. 2019 Jun;126:e671-e678. doi: 10.1016/j.wneu.2019.02.121. Epub 2019 Mar 4. World Neurosurg. 2019. PMID: 30844521
-
Middle meningeal artery embolization as an adjuvant treatment to surgery for symptomatic chronic subdural hematoma: a pilot study assessing hematoma volume resorption.J Neurointerv Surg. 2020 Jul;12(7):695-699. doi: 10.1136/neurintsurg-2019-015421. Epub 2019 Dec 20. J Neurointerv Surg. 2020. PMID: 31862830 Clinical Trial.
-
Usefulness of interventional embolization of the middle meningeal artery for recurrent chronic subdural hematoma: Five cases and a review of the literature.Interv Neuroradiol. 2015 Jun;21(3):366-71. doi: 10.1177/1591019915583224. Epub 2015 May 26. Interv Neuroradiol. 2015. PMID: 26015518 Free PMC article. Review.
-
Efficacy and mid-term outcome of middle meningeal artery embolization with or without burr hole evacuation for chronic subdural hematoma compared with burr hole evacuation alone.J Neurointerv Surg. 2022 Mar;14(3):297-300. doi: 10.1136/neurintsurg-2021-017450. Epub 2021 Jun 29. J Neurointerv Surg. 2022. PMID: 34187870
-
Embolization of the middle meningeal artery in patients with chronic subdural hematoma-a systematic review and meta-analysis.Acta Neurochir (Wien). 2020 Apr;162(4):777-784. doi: 10.1007/s00701-020-04266-0. Epub 2020 Feb 21. Acta Neurochir (Wien). 2020. PMID: 32086603
Cited by
-
Safety and efficacy comparison of embolic agents for middle meningeal artery embolization for chronic subdural hematoma.J Cerebrovasc Endovasc Neurosurg. 2024 Mar;26(1):11-22. doi: 10.7461/jcen.2023.E2023.04.002. Epub 2023 Oct 13. J Cerebrovasc Endovasc Neurosurg. 2024. PMID: 37828746 Free PMC article.
-
Extensive Roles and Technical Advances of Middle Meningeal Artery Embolization for Chronic Subdural Hematoma.Neurol Med Chir (Tokyo). 2023 Aug 15;63(8):327-333. doi: 10.2176/jns-nmc.2023-0017. Epub 2023 Jun 8. Neurol Med Chir (Tokyo). 2023. PMID: 37286481 Free PMC article. Review.
-
Discrimination of Hemorrhage and Contrast Media in a Head Phantom on Photon-Counting Detector CT Data.AJNR Am J Neuroradiol. 2024 Feb 7;45(2):183-187. doi: 10.3174/ajnr.A8093. AJNR Am J Neuroradiol. 2024. PMID: 38164551 Free PMC article.
-
Embolic Agent Choice in Middle Meningeal Artery Embolization as Primary or Adjunct Treatment for Chronic Subdural Hematoma: A Systematic Review and Meta-analysis.AJNR Am J Neuroradiol. 2023 Mar;44(3):297-302. doi: 10.3174/ajnr.A7796. Epub 2023 Feb 16. AJNR Am J Neuroradiol. 2023. PMID: 36797028 Free PMC article.
-
Bevacizumab: The future of chronic subdural hematoma.Interv Neuroradiol. 2024 Nov 21:15910199241298727. doi: 10.1177/15910199241298727. Online ahead of print. Interv Neuroradiol. 2024. PMID: 39569567 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical